DNase I inhibitions in tumors of different metastasizing capacities: a possible index of invasiveness.
Tumor pairs, selected on the basis of their different capacities to metastasize in vivo (SP73/AS and ASML from the rat, Eb/ESb from the mouse), have been assayed for their membrane associated actin through the DNase inhibition assay. It is found that, provided inhibitions per cell are corrected for the influence of gross heterogeneities in size distributions, the more metastatic tumor cells have significantly higher DNase I inhibitions than their less invasive counterparts. This observation, which extends our previous study of normal recirculating lymphocytes, is rationalized by postulating a participation of these actin pools to a property critical for both normal recirculation and metastatic spreading, arguments are presented which favor cell surface deformability as a possible candidate.
D000199:Actins / Q000032:analysis; D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D003208:Concanavalin A / Q000494:pharmacology; D003850:Deoxyribonuclease I; D004706:Endodeoxyribonucleases / Q000037:antagonists & inhibitors*; D005260:Female; D005354:Fibrosarcoma / Q000473:pathology; D008223:Lymphoma / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D051381:Rats
D000199:Actins; D003208:Concanavalin A; D004706:Endodeoxyribonucleases; D003850:Deoxyribonuclease I